Do patients with hepatitis B small three positives need antiviral therapy?
Generally, the "small three positives" of hepatitis B refer to a condition caused by the hepatitis B virus, characterized by positive results for hepatitis B surface antigen, hepatitis B e antibody, and hepatitis B core antibody, while hepatitis B e antigen is negative. Whether patients with hepatitis B require antiviral therapy depends on specific circumstances. If the patient's liver function is normal, antiviral treatment is usually unnecessary. However, if liver function is impaired, antiviral therapy may be needed. Detailed analysis is as follows:
If a patient's liver function and color ultrasound results are normal and there are no symptoms of discomfort, the patient is typically considered to be a hepatitis B virus carrier with inactive viral replication and no liver damage. In such cases, antiviral treatment is generally unnecessary, and regular follow-up visits to the hospital are sufficient to monitor liver health.
If a patient's liver function and color ultrasound results are abnormal, and symptoms such as liver area pain, decreased appetite, and fatigue appear, this usually indicates active hepatitis B viral replication and existing liver damage. At this point, timely medical consultation and antiviral treatment under the guidance of a specialist are necessary to prevent further liver damage.
In daily life, patients should maintain healthy lifestyle habits, avoid smoking and excessive alcohol consumption, and undergo regular follow-up examinations to promote overall health.